Recently, we reported the results of the FAEISS study (a phase III, open‐label, randomized trial evaluating topical corticosteroids for Facial Acneiform dermatitis by EGFR Inhibitors: Stepwise rank down from potent corticosteroids; NCCH1512, registered in the UMIN Clinical Trials Registry [www.umin.ac.jp/ctr/] as UMIN000024113), in which FAfR was treated with oral minocycline and a topical moisturizer followed by topical steroid therapy in patients with colorectal cancer [6]. Here, EGFR is linked to colorectal cancer.